Analysis for Sorrento Therapeutics, Inc. (SRNE)

Add SRNE to watchlist(s)

You Should Create a Watchlist In The First Place.

Price Over Time

Profile

Company Name

Sorrento Therapeutics, Inc.

Symbol

SRNE

Currency

USD

Exchange

Nasdaq

Head Quarter

United States, San Diego

Sector

Healthcare

Industry

Biotechnology

Website

https://www.sorrentotherapeutics.com

ISIN

US83587F2020

CIK

850261

CUSIP

83587F202

UEI

-

LEI

-

Business Description

Sorrento Therapeutics, Inc., a clinical stage and commercial biopharmaceutical company, develops therapies for cancer, autoimmune, inflammatory, viral, and neurodegenerative diseases. It operates through two segments, Sorrento Therapeutics and Scilex. The company provides cancer therapeutic by leveraging its proprietary G-MAB antibody library and targeted delivery modalities, which include chimeric antigen receptor T-cell therapy (CAR-T), dimeric antigen receptor T-cell therapy, and antibody drug conjugate, as well as bispecific antibody approach; and Sofusa, a drug delivery technology that deliver biologic directly into the lymphatic system.